Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Gut microbiome for predicting immune checkpoint blockade-associated adverse events

Fig. 2

Alterations of gut microbial composition with different irAEs status among three anti-PD-1/PD-L1 cohorts. A Variance explained by irAEs status (irAEs versus non-irAEs) is plotted against variance explained by study effects for individual ASVs. The significantly differential ASVs are colored in red and the dot size is proportional to the abundance of each ASV. P values were from a two-sided blocked Wilcoxon rank-sum test. B Relative abundance of bacterial phyla in irAEs and non-irAEs across all three different studies. C Alpha diversity analysis calculated with Fisher alpha, Richness, Shannon, and Simpson indexes. D Principal coordinate analysis of samples (irAEs: n = 77; non-irAEs: n = 113) from all three anti-PD-1 studies based on Bray–Curtis distance. P values of beta diversity based on Bray–Curtis distance were calculated with PERMANOVA. The study is color-coded and the group (irAEs and non-irAEs) is indicated by different shapes. The upper-right and the bottom-left boxplots illustrate that samples projected onto the first two principal coordinates broken down by study and disease status, respectively. P values of the first and second principal components were calculated with a two-sided Kruskal–Wallis test for study and group. All boxplots represent the 25th–75th percentile of the distribution; the median is shown in a thick line at the middle of the box; the whiskers extend up to values within 1.5 times of IQR, and outliers are represented as dots. The anti-PD1/PD-L1 cohorts comprising over 50 patients, such as those led by Zhang et al., Hakozaki et al., and McCulloch et al., were utilized for the analysis in this part

Back to article page